+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Molecular Diagnostics Market: By Products Technology End Users Applications - Forecast 2017-2022

  • ID: 3501342
  • Report
  • 73 pages
  • IndustryARC
1 of 2
Molecular Diagnostics is a diasnosis technique that utilizes DNA, RNA and proteins to detect specific health condition or diseases. Molecular Diagnostics represents enormous market growth of in-vitro diagnostics and now-a-days routinely used in hospitals, reference labs, and blood banks.

This report gives an in-depth segmentation of the market by products, technology and applications. It also segmented by end user verticals and key geographic regions like Americas, Europe and Asia-pacific. Cost analysis, pricing analysis and the overall competitive landscape of key players are also analyzed in great detail in the report.

Competitive landscape for each of the product types is highlighted and market players are profiled with attributes of company overview, financial overview, business strategies, product portfolio and recent developments. Market shares of the key players for 2014 are provided.

The prominent players profiled in this report are:
Abbott Diagnostics
Beckman Coulter
Becton
Dickinson & Co
Biomérieux.

The report contains the most detailed and in-depth segmentation of the global Molecular Diagnostics market.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 2
1. Molecular Diagnostics Market - Market Overview

2. Executive Summary

3. Molecular Diagnostics Market - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis

4. Molecular Diagnostics Market - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition

5. Molecular Diagnostics Market – Government Regulations

6. Molecular Diagnostics Market – Strategic Analysis
6.1. Value Chain Analysis
6.2. Pricing Analysis
6.3. Opportunities Analysis
6.4. Product/Market Life Cycle Analysis

7. Molecular Diagnostics Market – By Products
7.1. Analyzers
7.2. Reagents

8. Molecular Diagnostics Market – By Technology
8.1. PCR
8.2. INAAT
8.3. Hybridization
8.4. DNA Sequencing and Next Generation Sequencing
8.5. Microarray
8.6. Spectral Karyotype Imaging (SKI)
8.7. Others

9. Molecular Diagnostics Market – By End Users
9.1. Hospitals
9.2. Clinical Laboratories
9.3. Academics

10. Molecular Diagnostics Market – By Applications
10.1. Infectious Disease
10.1.1. HBV
10.1.2. HCV
10.1.3. HIV
10.1.4. TB
10.1.5. CT/NG
10.1.6. HPV
10.1.7. MRSA
10.1.8. Others
10.2. Oncology
10.2.1. Prostate Cancer
10.2.2. Breast Cancer
10.2.3. Colorectal Cancer
10.2.4. Others
10.3. Genetic Disease Screening
10.4. Blood Screening
10.5. Microbiology
10.6. Others

11. Molecular Diagnostics Market - Geographic Analysis
11.1. Americas
11.2. Europe
11.3. APAC
11.4. ROW

12. Market Entropy
12.1. New Product Launches
12.2. M&As, Collaborations, JVs and Partnerships

13. Company Profiles (Overview, Financials, SWOT Analysis – Top 5 Companies, Developments, Product Portfolio)
13.1. Abbott Diagnostics, Inc.
13.2. Beckman Coulter, Inc.
13.3. Becton, Dickinson & Co.
13.4. Biomérieux
13.5. Cepheid, Inc.
13.6. Gen-Probe, Inc. (Hologic, Inc.)
13.7. Novartis AG
13.8. Qiagen N.V.
13.9. F. Hoffmann-La Roche Ltd.
13.10. Siemens Healthcare
13.11. Myriad Genetics, Inc.
13.12. Danaher Corporation
13.13. Bio-Rad Laboratories, Inc.
13.14. Quest Diagnostics, Inc.
13.15. Thermo Fisher Scientific
13.16. Johnson and Johnson
13.17. Sysmex
13.18. Bayer Healthcare AG
13.19. Alere Inc.
13.20. Leica Biosystems
13.21. Agilient Technologies, Inc
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
14. Appendix
14.1. Abbreviations
14.2. Sources
14.3. Research Methodology
14.4. Bibliography
14.5. Compilation of Expert Insights
14.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll